Correction: Neurol Ther (2024) 13:655–675 10.1007/s40120-024-00600-1
A graphical abstract is now available for this publication. The graphical abstract can also be accessed on the article’s Figshare page here: 10.6084/m9.figshare.26819554.
. 2024 Sep 12;13(6):1747–1749. doi: 10.1007/s40120-024-00660-3
Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
Samuel Frank
1,✉, Karen E Anderson
2, Hubert H Fernandez
3, Robert A Hauser
4, Daniel O Claassen
5, David Stamler
6, Stewart A Factor
7, Joohi Jimenez-Shahed
8, Hadas Barkay
9, Amanda Wilhelm
10, Jessica K Alexander
10, Nayla Chaijale
10, Steve Barash
10, Juha-Matti Savola
11, Mark Forrest Gordon
10, Maria Chen
10
Samuel Frank
1Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA 02215 USA
Find articles by Samuel Frank
Robert A Hauser
4University of South Florida Parkinson’s Disease and Movement Disorders Center, Tampa, FL USA
Find articles by Robert A Hauser
Daniel O Claassen
5Vanderbilt University Medical Center, Nashville, TN USA
Find articles by Daniel O Claassen
David Stamler
6Teva Branded Pharmaceutical Products R&D, Inc., La Jolla, CA USA
Find articles by David Stamler
Joohi Jimenez-Shahed
8Icahn School of Medicine at Mount Sinai, New York, NY USA
Find articles by Joohi Jimenez-Shahed
Amanda Wilhelm
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
Find articles by Amanda Wilhelm
Jessica K Alexander
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
Find articles by Jessica K Alexander
Nayla Chaijale
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
Find articles by Nayla Chaijale
Steve Barash
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
Find articles by Steve Barash
Juha-Matti Savola
11Teva Pharmaceuticals International GmbH, Basel, Switzerland
Find articles by Juha-Matti Savola
Mark Forrest Gordon
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
Find articles by Mark Forrest Gordon
Maria Chen
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
Find articles by Maria Chen
1Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA 02215 USA
2Georgetown University, Washington, DC, USA
3Cleveland Clinic, Cleveland, OH USA
4University of South Florida Parkinson’s Disease and Movement Disorders Center, Tampa, FL USA
5Vanderbilt University Medical Center, Nashville, TN USA
6Teva Branded Pharmaceutical Products R&D, Inc., La Jolla, CA USA
7Emory University, Atlanta, GA USA
8Icahn School of Medicine at Mount Sinai, New York, NY USA
9Teva Pharmaceutical Industries Ltd., Netanya, Israel
10Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA USA
11Teva Pharmaceuticals International GmbH, Basel, Switzerland
✉
Corresponding author.
Collection date 2024 Dec.
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC11541967 PMID: 39266813
This corrects the article "Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease" on page 655.